Compare ABT & XOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABT | XOM |
|---|---|---|
| Founded | 1888 | 1870 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.9B | 616.0B |
| IPO Year | 2006 | 2005 |
| Metric | ABT | XOM |
|---|---|---|
| Price | $93.28 | $136.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 25 |
| Target Price | $130.90 | ★ $153.54 |
| AVG Volume (30 Days) | 9.6M | ★ 11.9M |
| Earning Date | 04-16-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.76% | 2.66% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.61 | ★ 1.00 |
| Revenue | $44,328,000,000.00 | ★ $332,238,000,000.00 |
| Revenue This Year | $10.75 | $16.41 |
| Revenue Next Year | $8.10 | N/A |
| P/E Ratio | $152.64 | ★ $137.41 |
| Revenue Growth | ★ 5.67 | N/A |
| 52 Week Low | $81.97 | $105.53 |
| 52 Week High | $137.49 | $176.41 |
| Indicator | ABT | XOM |
|---|---|---|
| Relative Strength Index (RSI) | 61.79 | 33.42 |
| Support Level | $86.02 | $112.54 |
| Resistance Level | $112.81 | $155.81 |
| Average True Range (ATR) | 2.26 | 2.91 |
| MACD | 0.59 | -0.85 |
| Stochastic Oscillator | 77.89 | 8.27 |
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil worldwide. In 2025, it produced 3.3 million barrels of liquids and 8.4 billion cubic feet of natural gas per day. At the end of 2025, reserves were 19.3 billion barrels of oil equivalent, 69% of which were liquids. The company is one of the world's largest refiners, with a total global refining capacity of 4.1 million barrels of oil per day, and is one of the world's largest manufacturers of commodity and specialty chemicals.